OPTIMIZATION OF TREATMENT OF BACTERIAL VAGINOSIS
Abstract
Comparative analysis of 3 therapeutical schemes was made. 44 patients of the I group received simultaneously antibiotic and probiotic during 7 days, 42 patients of II group 7 days received antibiotic and next 1 week-probiotic. 40 patients of III group were using only antibiotic, during 7 days. Both combinative schemes were characterized by the identical results. Monotherapy by antibiotic showed the less effectiveness and predisposition for recidives.
Downloads
References
Atashili J., Poole C. et all. Bacterial vaginosis and HIV acquisition: a metanalysis of published studies. AIDS. 2008; 22: 1493-1501.
Chohan V.H., Baeten J. et all. A prospective study of risk factors for herpes simplex virus type 2 Acquisition among highrisk HIVI Zero negative Kenyan Women. Sex. Transm. Infect. 2009; 85: 489-492.
David A. Eschenbach. Bacterial Vaginosis: Resistance, Recurrence, and/or Reinfection? Clinical Infectious Diseases. 2007; 44(2): 220-221.
Federal Clinical recommendations of the ROAG, Diagnosis and treatment of diseases accompanied by pathological secretions from the genital tract of women’’, 2019.
Larsson P.G., Platz Cristensen J.J. et all. Incidence of pelvic inflammatory disease after first trimester legal abortion in women with bacterial vaginosis after treatment with metronidazole: a double-blind, randomized study. ,,Am. J. Obstet. Gynecol.’’ 1992; 166(1 Pt. 1): 100-103.
Macklaim J.M., Clemente J.C. et all. Changes in vaginal microbiota following antimicrobial and probiotic therapy. ,,Microb. Ecol. Health Dis.’’ 2015; 26: 277-99.
The cervix, vagina, vulva, physiology, pathology, colposcopy, aesthetic correction: a guide for practitioners; Edited by S.I. Rogovskaya, E.V. Lipova. Moscow: publishing house of the journal Status Praesens; 2014, 250p.
Van de Wijgert J.H., Morrison C.S. et all. Bacterial vaginosis and vaginal yeast, but not vaginal cleansing; increase HIVI acquisition in African women. ,,J Acquir. Immune. Defc. Syndr.’’ 2008; 48: 203-209.
